She developed ataxia at 17 years of age and clinical symptoms including cerebellar ataxia, mild spastic paraparesis, neuropathy, cerebellum atrophy and elevated serum AFP, without oculomotor apraxia, dystonia and cognitive impairment (Bernard et al., 2008). The gene discussed is AFP; the disease is Oculomotor apraxia.